Studies have failed to find evidence that GLP-1 use can cause pancreatic cancer, a possible complication of pancreatitis, so theres still some uncertainty about the exact nature of harm that GLP-1s can cause to the pancreas
As a general guide based on class experience, symptoms following a dose increase often begin to settle within one to two weeks, though this timeframe is not derived from retatrutide-specific data and individual experience will vary
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al
Therefore, these data are not shown
These compounded formulations from licensed 503A pharmacies may support sustained, affordable therapy if recommended by your provider